小儿变应性鼻炎的临床治疗

The Treatment of Allergic Rhinitis in Children

国内外大量的流行病学调查显示,近年来过敏性鼻炎(allergic rhinitis, AR)的患病率明显上升,保守估计全球的AR患者超过5亿,有报道显示国内11个城市AR自报患病率平均为11%,2008年~2009年在北京、重庆和广州市以0~14岁儿童为对象的问卷调查中,AR自报患病率分别为14.46%、20.42%和7.83%,且有逐年上升趋势。AR已成为主要的呼吸道慢性炎症之一,长期鼻炎不仅影响小儿生长发育,也严重影响了患儿和家庭成员的身心健康和生活质量。本文将小儿过敏性鼻炎的治疗进行如下阐述。

A large number of epidemiological investigations at home and abroad have shown that the prevalence of allergic rhinitis has increased significantly in recent years. It is conservatively estimated that there are more than 500 million AR patients in the world. From 2008 to 2009, the prevalence of AR among children aged 0~14 in Beijing, Chongqing and Guangzhou was 14.46%, 20.42% and 7.83%, respectively. AR has become one of the main chronic inflammations of respiratory tract. Long-term rhinitis not only affects the growth and development of children, but also seriously affects the physical and mental health and quality of life of children and family members. This article describes the treatment of Allergic Rhinitis in children.